Download presentation
Presentation is loading. Please wait.
1
Diabetes Mellitus Nursing Management
2
Diabetes Mellitus A group of metabolic diseases characterized by inappropriate hyperglycemia resulting from defects in insulin secretion, insulin action or both Chronic systemic disease Abnormalities in carbohydrate, protein, fat and insulin metabolism Abnormalities in the structure and function of blood vessels and nerves
3
Significance $245 billion dollars per year $176 in direct medical cost
$69 billion in lost productivity
4
Pathology Immune mediated response
Genetically determined beta cell dysfunction Impaired insulin secretion Acquired beta cell dysfunction (glucose toxicity) Persistant hepatic glucose production Diminished glucose disposal Terms: Glucagon Gluconeogenesis Glycogen Glycogenolysis Lactate
5
Diagnostic criteria All are confirmed on subsequent day testing
A1C 6.5% or greater (exception) Acute symptoms plus casual blood glucose >200 mg/dL Fasting glucose >126 mg/dL 2-hour plasma glucose >200 mg/dL during a 75 gram oral glucose load Impaired fasting glucose: >100 mg/dL and <126 mg/dL (represents impaired glucose homeostasis) Impaired glucose tolerance: 2-hour OGTT are >140 mg/dL but < 200 mg/dL
6
Characteristics of Type 1 and 2
More common in youth Abrupt onset Absent or minimal insulin Thin, catabolic state Thirst, polyuria, polyphagia, fatigue, weight loss Prone to ketosis Nutritional therapy essential Insulin required for all Frequent vascular and neurologic complications 35 yoa or older Insidious Insulin resistance Obese or possibly normal Frequently none, fatigue, recurrent infections Ketosis resistant except during infection or stress Nutritional therapy essential Insulin required for some Frequent vascular and neurologic complications
7
Insulin Therapy Types of insulin Insulin regimens
Mealtime insulin Long acting basal insulin Combination therapy Problems with insulin therapy Allergic reactions Lipodystrophy Somogyi effect and dawn phenomenon
8
Drug Therapy: Oral Agents
Sulfonylureas Meglitindes Biguanides Alpha glucosidase inhibitors Thiazolidinediones (glitazones)
9
Nutrition Therapy Type I: Meal planning is based on usual food intake and balanced with insulin and exercise patterns Type II: Emphasis is based on achieving glucose, lipid and blood pressure Food composition Carbs: 50% Protein: 20% or less Fats: 30%
10
Metabolic Complications: Acute
DKA HHS Hypoglycemia
11
Chronic Complications
Hypertension Dyslipidemia Neuropathy Foot ulcers Skin and dental Nephropathy Retinopathy Long term problems: cataracts, glaucoma, depression
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.